Regen BioPharma (United States)

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

• Immunology and Microbiology 8.2×
• Medicine 4.8×

By volume in 2022–2025: Sexual function and dysfunction studies, Ovarian function and disorders, Periodontal Regeneration and Treatments and Reproductive System and Pregnancy.

1. 1 Sexual function and dysfunction studies Psychiatry and Mental health 1 works
2. 2 Ovarian function and disorders Reproductive Medicine 0 works
3. 3 Periodontal Regeneration and Treatments Urology 0 works
4. 4 Reproductive System and Pregnancy Immunology 0 works
5. 5 Reproductive Biology and Fertility Public Health, Environmental and Occupational Health 0 works
6. 6 Hormonal and reproductive studies Endocrinology, Diabetes and Metabolism 0 works
7. 7 Sperm and Testicular Function Reproductive Medicine 0 works
8. 8 Urological Disorders and Treatments Urology 0 works
9. 9 Vascular Procedures and Complications Pulmonary and Respiratory Medicine 0 works
10. 10 Antiplatelet Therapy and Cardiovascular Diseases Cardiology and Cardiovascular Medicine 0 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 49% lower than in 2013–2017.

• Sharp Grossmont Hospital
• Source Signal Imaging
• Capita Foundation
• Grossmont Hospital Foundation
• Challenge Center